<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>3.524e-04</TD><TD>-7.95</TD><TD>KLHL8</TD><TD>interpro domains</TD><TD>IPR030605</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.524e-04</TD><TD>-7.95</TD><TD>Spo12</TD><TD>interpro domains</TD><TD>IPR007727</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>Y69A2AR.28</TD></TR>
<TR><TD>3.927e-04</TD><TD>-7.84</TD><TD>Spo12</TD><TD>pfam domains</TD><TD>PF05032</TD><TD>1</TD><TD>1</TD><TD>12733</TD><TD>5</TD>
<TD>Y69A2AR.28</TD></TR>
<TR><TD>8.616e-04</TD><TD>-7.06</TD><TD>Cul3-RING ubiquitin ligase complex</TD><TD>cellular component</TD><TD>GO:0031463</TD><TD>5</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>9.512e-04</TD><TD>-6.96</TD><TD>GP1b-IX-V activation signalling</TD><TD>REACTOME pathways</TD><TD>R-CEL-430116</TD><TD>3</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.057e-03</TD><TD>-6.85</TD><TD>14-3-3</TD><TD>interpro domains</TD><TD>IPR000308</TD><TD>3</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.057e-03</TD><TD>-6.85</TD><TD>14-3-3_domain</TD><TD>interpro domains</TD><TD>IPR023410</TD><TD>3</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.057e-03</TD><TD>-6.85</TD><TD>14-3-3_dom_sf</TD><TD>interpro domains</TD><TD>IPR036815</TD><TD>3</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.101e-03</TD><TD>-6.81</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.20.190.20</TD><TD>3</TD><TD>1</TD><TD>5448</TD><TD>2</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.178e-03</TD><TD>-6.74</TD><TD>14-3-3</TD><TD>pfam domains</TD><TD>PF00244</TD><TD>3</TD><TD>1</TD><TD>12733</TD><TD>5</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.288e-03</TD><TD>-6.66</TD><TD>1433ZETA</TD><TD>prints domains</TD><TD>PR00305</TD><TD>3</TD><TD>1</TD><TD>2330</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.524e-03</TD><TD>-6.49</TD><TD>arf-1.2 (ADP-ribosylation factor 1-like 2)</TD><TD>protein interactions</TD><TD>175801</TD><TD>6</TD><TD>1</TD><TD>3938</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.585e-03</TD><TD>-6.45</TD><TD>TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest</TD><TD>REACTOME pathways</TD><TD>R-CEL-6804114</TD><TD>5</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.585e-03</TD><TD>-6.45</TD><TD>Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex</TD><TD>REACTOME pathways</TD><TD>R-CEL-75035</TD><TD>5</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.113e-03</TD><TD>-6.16</TD><TD>BTB-kelch_protein</TD><TD>interpro domains</TD><TD>IPR017096</TD><TD>6</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>2.219e-03</TD><TD>-6.11</TD><TD>G2/M DNA damage checkpoint</TD><TD>REACTOME pathways</TD><TD>R-CEL-69473</TD><TD>7</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.536e-03</TD><TD>-5.98</TD><TD>RHO GTPases activate PKNs</TD><TD>REACTOME pathways</TD><TD>R-CEL-5625740</TD><TD>8</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.558e-03</TD><TD>-5.97</TD><TD>GO_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX</TD><TD>MSigDB lists</TD><TD>GO_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX</TD><TD>9</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>2.793e-03</TD><TD>-5.88</TD><TD>pas-6 (Proteasome subunit alpha type-1)</TD><TD>protein interactions</TD><TD>178943</TD><TD>11</TD><TD>1</TD><TD>3938</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>2.854e-03</TD><TD>-5.86</TD><TD>Rap1 signalling</TD><TD>REACTOME pathways</TD><TD>R-CEL-392517</TD><TD>9</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.047e-03</TD><TD>-5.79</TD><TD>pas-2 (Proteasome subunit alpha type-2)</TD><TD>protein interactions</TD><TD>179493</TD><TD>12</TD><TD>1</TD><TD>3938</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.100e-03</TD><TD>-5.78</TD><TD>neuron to neuron synapse</TD><TD>cellular component</TD><TD>GO:0098984</TD><TD>18</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.100e-03</TD><TD>-5.78</TD><TD>asymmetric synapse</TD><TD>cellular component</TD><TD>GO:0032279</TD><TD>18</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.100e-03</TD><TD>-5.78</TD><TD>postsynaptic density</TD><TD>cellular component</TD><TD>GO:0014069</TD><TD>18</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.171e-03</TD><TD>-5.75</TD><TD>TP53 Regulates Transcription of Cell Cycle Genes</TD><TD>REACTOME pathways</TD><TD>R-CEL-6791312</TD><TD>10</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.444e-03</TD><TD>-5.67</TD><TD>postsynaptic specialization</TD><TD>cellular component</TD><TD>GO:0099572</TD><TD>20</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>RAF activation</TD><TD>REACTOME pathways</TD><TD>R-CEL-5673000</TD><TD>11</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.668e-03</TD><TD>-5.61</TD><TD>Kelch</TD><TD>smart domains</TD><TD>SM00612</TD><TD>10</TD><TD>1</TD><TD>5448</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.805e-03</TD><TD>-5.57</TD><TD>MAP2K and MAPK activation</TD><TD>REACTOME pathways</TD><TD>R-CEL-5674135</TD><TD>12</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.809e-03</TD><TD>-5.57</TD><TD>atp-2 (ATP synthase subunit beta, mitochondrial)</TD><TD>protein interactions</TD><TD>175716</TD><TD>15</TD><TD>1</TD><TD>3938</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.222e-03</TD><TD>-5.47</TD><TD>Kelch_1</TD><TD>interpro domains</TD><TD>IPR006652</TD><TD>12</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.547e-03</TD><TD>-5.39</TD><TD>chr4q21</TD><TD>MSigDB lists</TD><TD>chr4q21</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.547e-03</TD><TD>-5.39</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</TD><TD>MSigDB lists</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.704e-03</TD><TD>-5.36</TD><TD>Kelch_1</TD><TD>pfam domains</TD><TD>PF01344</TD><TD>12</TD><TD>1</TD><TD>12733</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.767e-03</TD><TD>-5.35</TD><TD>BACK</TD><TD>smart domains</TD><TD>SM00875</TD><TD>13</TD><TD>1</TD><TD>5448</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.825e-03</TD><TD>-5.33</TD><TD>pas-4 (Proteasome subunit alpha type-7)</TD><TD>protein interactions</TD><TD>172679</TD><TD>19</TD><TD>1</TD><TD>3938</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>5.275e-03</TD><TD>-5.24</TD><TD>BACK</TD><TD>interpro domains</TD><TD>IPR011705</TD><TD>15</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>5.390e-03</TD><TD>-5.22</TD><TD>KSRP (KHSRP) binds and destabilizes mRNA</TD><TD>REACTOME pathways</TD><TD>R-CEL-450604</TD><TD>17</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>5.390e-03</TD><TD>-5.22</TD><TD>Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA</TD><TD>REACTOME pathways</TD><TD>R-CEL-450385</TD><TD>17</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>5.486e-03</TD><TD>-5.21</TD><TD>BACK</TD><TD>pfam domains</TD><TD>PF07707</TD><TD>14</TD><TD>1</TD><TD>12733</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>5.683e-03</TD><TD>-5.17</TD><TD>GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN</TD><TD>MSigDB lists</TD><TD>GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN</TD><TD>20</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>5.707e-03</TD><TD>-5.17</TD><TD>Deactivation of the beta-catenin transactivating complex</TD><TD>REACTOME pathways</TD><TD>R-CEL-3769402</TD><TD>18</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>5.977e-03</TD><TD>-5.12</TD><TD>Kelch-typ_b-propeller</TD><TD>interpro domains</TD><TD>IPR015915</TD><TD>17</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>6.232e-03</TD><TD>-5.08</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.120.10.80</TD><TD>17</TD><TD>1</TD><TD>5448</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>6.658e-03</TD><TD>-5.01</TD><TD>Negative regulation of MAPK pathway</TD><TD>REACTOME pathways</TD><TD>R-CEL-5675221</TD><TD>21</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>6.820e-03</TD><TD>-4.99</TD><TD>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP</TD><TD>MSigDB lists</TD><TD>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP</TD><TD>24</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>7.388e-03</TD><TD>-4.91</TD><TD>GO_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX</TD><TD>MSigDB lists</TD><TD>GO_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX</TD><TD>26</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>7.673e-03</TD><TD>-4.87</TD><TD>GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>7.926e-03</TD><TD>-4.84</TD><TD>Regulation of mRNA stability by proteins that bind AU-rich elements</TD><TD>REACTOME pathways</TD><TD>R-CEL-450531</TD><TD>25</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>8.241e-03</TD><TD>-4.80</TD><TD>GSE4142_NAIVE_VS_GC_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE4142_NAIVE_VS_GC_BCELL_UP</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>8.275e-03</TD><TD>-4.79</TD><TD>apoptotic cell clearance</TD><TD>biological process</TD><TD>GO:0043277</TD><TD>38</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>8.525e-03</TD><TD>-4.76</TD><TD>GSE2706_UNSTIM_VS_2H_R848_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_2H_R848_DC_UP</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>8.709e-03</TD><TD>-4.74</TD><TD>phagocytosis</TD><TD>biological process</TD><TD>GO:0006909</TD><TD>40</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>8.809e-03</TD><TD>-4.73</TD><TD>GO_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_UBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>8.878e-03</TD><TD>-4.72</TD><TD>G2/M Checkpoints</TD><TD>REACTOME pathways</TD><TD>R-CEL-69481</TD><TD>28</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>9.662e-03</TD><TD>-4.64</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP</TD><TD>34</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.023e-02</TD><TD>-4.58</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP</TD><TD>MSigDB lists</TD><TD>GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP</TD><TD>36</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.051e-02</TD><TD>-4.56</TD><TD>GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP</TD><TD>MSigDB lists</TD><TD>GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP</TD><TD>37</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.051e-02</TD><TD>-4.56</TD><TD>GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN</TD><TD>37</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.108e-02</TD><TD>-4.50</TD><TD>GSE6875_TCONV_VS_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE6875_TCONV_VS_TREG_UP</TD><TD>39</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.137e-02</TD><TD>-4.48</TD><TD>GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN</TD><TD>MSigDB lists</TD><TD>GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN</TD><TD>40</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.141e-02</TD><TD>-4.47</TD><TD>TCF dependent signaling in response to WNT</TD><TD>REACTOME pathways</TD><TD>R-CEL-201681</TD><TD>36</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.203e-02</TD><TD>-4.42</TD><TD>cullin-RING ubiquitin ligase complex</TD><TD>cellular component</TD><TD>GO:0031461</TD><TD>70</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.222e-02</TD><TD>-4.40</TD><TD>GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP</TD><TD>43</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.307e-02</TD><TD>-4.34</TD><TD>GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN</TD><TD>46</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.323e-02</TD><TD>-4.33</TD><TD>postsynapse</TD><TD>cellular component</TD><TD>GO:0098794</TD><TD>77</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.336e-02</TD><TD>-4.32</TD><TD>GSE30083_SP2_VS_SP3_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE30083_SP2_VS_SP3_THYMOCYTE_UP</TD><TD>47</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.336e-02</TD><TD>-4.32</TD><TD>GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN</TD><TD>MSigDB lists</TD><TD>GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN</TD><TD>47</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.364e-02</TD><TD>-4.29</TD><TD>GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP</TD><TD>48</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.392e-02</TD><TD>-4.27</TD><TD>GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN</TD><TD>MSigDB lists</TD><TD>GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN</TD><TD>49</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.449e-02</TD><TD>-4.23</TD><TD>GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP</TD><TD>51</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.511e-02</TD><TD>-4.19</TD><TD>protein domain specific binding</TD><TD>molecular function</TD><TD>GO:0019904</TD><TD>71</TD><TD>1</TD><TD>9362</TD><TD>2</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>GRB2 events in EGFR signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-179812</TD><TD>49</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>SHC1 events in EGFR signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-180336</TD><TD>49</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>Signalling to p38 via RIT and RIN</TD><TD>REACTOME pathways</TD><TD>R-CEL-187706</TD><TD>49</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>Interleukin receptor SHC signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-912526</TD><TD>49</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>RET signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-8853659</TD><TD>49</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>SOS-mediated signalling</TD><TD>REACTOME pathways</TD><TD>R-CEL-112412</TD><TD>49</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>RAF/MAP kinase cascade</TD><TD>REACTOME pathways</TD><TD>R-CEL-5673001</TD><TD>49</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.563e-02</TD><TD>-4.16</TD><TD>GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN</TD><TD>55</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.585e-02</TD><TD>-4.14</TD><TD>Interleukin-2 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-451927</TD><TD>50</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.585e-02</TD><TD>-4.14</TD><TD>Signaling by Leptin</TD><TD>REACTOME pathways</TD><TD>R-CEL-2586552</TD><TD>50</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.585e-02</TD><TD>-4.14</TD><TD>RHO GTPase Effectors</TD><TD>REACTOME pathways</TD><TD>R-CEL-195258</TD><TD>50</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.585e-02</TD><TD>-4.14</TD><TD>MAPK1/MAPK3 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5684996</TD><TD>50</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.591e-02</TD><TD>-4.14</TD><TD>LEE_RECENT_THYMIC_EMIGRANT</TD><TD>MSigDB lists</TD><TD>LEE_RECENT_THYMIC_EMIGRANT</TD><TD>56</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.617e-02</TD><TD>-4.12</TD><TD>NCAM signaling for neurite out-growth</TD><TD>REACTOME pathways</TD><TD>R-CEL-375165</TD><TD>51</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.620e-02</TD><TD>-4.12</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP</TD><TD>57</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.620e-02</TD><TD>-4.12</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_UP</TD><TD>57</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.620e-02</TD><TD>-4.12</TD><TD>GO_UBIQUITIN_LIGASE_COMPLEX</TD><TD>MSigDB lists</TD><TD>GO_UBIQUITIN_LIGASE_COMPLEX</TD><TD>57</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.649e-02</TD><TD>-4.11</TD><TD>Frs2-mediated activation</TD><TD>REACTOME pathways</TD><TD>R-CEL-170968</TD><TD>52</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.680e-02</TD><TD>-4.09</TD><TD>ARMS-mediated activation</TD><TD>REACTOME pathways</TD><TD>R-CEL-170984</TD><TD>53</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.680e-02</TD><TD>-4.09</TD><TD>Signalling to RAS</TD><TD>REACTOME pathways</TD><TD>R-CEL-167044</TD><TD>53</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.712e-02</TD><TD>-4.07</TD><TD>VEGFR2 mediated cell proliferation</TD><TD>REACTOME pathways</TD><TD>R-CEL-5218921</TD><TD>54</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.712e-02</TD><TD>-4.07</TD><TD>Prolonged ERK activation events</TD><TD>REACTOME pathways</TD><TD>R-CEL-169893</TD><TD>54</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.712e-02</TD><TD>-4.07</TD><TD>Interleukin-3, 5 and GM-CSF signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-512988</TD><TD>54</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.744e-02</TD><TD>-4.05</TD><TD>MAPK family signaling cascades</TD><TD>REACTOME pathways</TD><TD>R-CEL-5683057</TD><TD>55</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.802e-02</TD><TD>-4.02</TD><TD>ubiquitin ligase complex</TD><TD>cellular component</TD><TD>GO:0000151</TD><TD>105</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>1.807e-02</TD><TD>-4.01</TD><TD>FCERI mediated MAPK activation</TD><TD>REACTOME pathways</TD><TD>R-CEL-2871796</TD><TD>57</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.839e-02</TD><TD>-4.00</TD><TD>Signalling to ERKs</TD><TD>REACTOME pathways</TD><TD>R-CEL-187687</TD><TD>58</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>1.933e-02</TD><TD>-3.95</TD><TD>apoptotic process</TD><TD>biological process</TD><TD>GO:0006915</TD><TD>89</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>2.018e-02</TD><TD>-3.90</TD><TD>GABRIELY_MIR21_TARGETS</TD><TD>MSigDB lists</TD><TD>GABRIELY_MIR21_TARGETS</TD><TD>71</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>2.061e-02</TD><TD>-3.88</TD><TD>Signaling by Interleukins</TD><TD>REACTOME pathways</TD><TD>R-CEL-449147</TD><TD>65</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.124e-02</TD><TD>-3.85</TD><TD>Signaling by SCF-KIT</TD><TD>REACTOME pathways</TD><TD>R-CEL-1433557</TD><TD>67</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.131e-02</TD><TD>-3.85</TD><TD>Glyco_transf_92</TD><TD>interpro domains</TD><TD>IPR008166</TD><TD>61</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>C31B8.7</TD></TR>
<TR><TD>2.160e-02</TD><TD>-3.84</TD><TD>GO_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY</TD><TD>76</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>2.188e-02</TD><TD>-3.82</TD><TD>VEGFA-VEGFR2 Pathway</TD><TD>REACTOME pathways</TD><TD>R-CEL-4420097</TD><TD>69</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.188e-02</TD><TD>-3.82</TD><TD>Signaling by VEGF</TD><TD>REACTOME pathways</TD><TD>R-CEL-194138</TD><TD>69</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.235e-02</TD><TD>-3.80</TD><TD>programmed cell death</TD><TD>biological process</TD><TD>GO:0012501</TD><TD>103</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>2.251e-02</TD><TD>-3.79</TD><TD>Insulin receptor signalling cascade</TD><TD>REACTOME pathways</TD><TD>R-CEL-74751</TD><TD>71</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.251e-02</TD><TD>-3.79</TD><TD>IRS-mediated signalling</TD><TD>REACTOME pathways</TD><TD>R-CEL-112399</TD><TD>71</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.251e-02</TD><TD>-3.79</TD><TD>IGF1R signaling cascade</TD><TD>REACTOME pathways</TD><TD>R-CEL-2428924</TD><TD>71</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.251e-02</TD><TD>-3.79</TD><TD>Gastrin-CREB signalling pathway via PKC and MAPK</TD><TD>REACTOME pathways</TD><TD>R-CEL-881907</TD><TD>71</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.251e-02</TD><TD>-3.79</TD><TD>IRS-related events triggered by IGF1R</TD><TD>REACTOME pathways</TD><TD>R-CEL-2428928</TD><TD>71</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.251e-02</TD><TD>-3.79</TD><TD>Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)</TD><TD>REACTOME pathways</TD><TD>R-CEL-2404192</TD><TD>71</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.283e-02</TD><TD>-3.78</TD><TD>Cell Cycle Checkpoints</TD><TD>REACTOME pathways</TD><TD>R-CEL-69620</TD><TD>72</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.321e-02</TD><TD>-3.76</TD><TD>cell death</TD><TD>biological process</TD><TD>GO:0008219</TD><TD>107</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>2.373e-02</TD><TD>-3.74</TD><TD>Glyco_transf_92</TD><TD>pfam domains</TD><TD>PF01697</TD><TD>61</TD><TD>1</TD><TD>12733</TD><TD>5</TD>
<TD>C31B8.7</TD></TR>
<TR><TD>2.410e-02</TD><TD>-3.73</TD><TD>DAP12 interactions</TD><TD>REACTOME pathways</TD><TD>R-CEL-2172127</TD><TD>76</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.410e-02</TD><TD>-3.73</TD><TD>Signaling by PDGF</TD><TD>REACTOME pathways</TD><TD>R-CEL-186797</TD><TD>76</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.410e-02</TD><TD>-3.73</TD><TD>Downstream signal transduction</TD><TD>REACTOME pathways</TD><TD>R-CEL-186763</TD><TD>76</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.410e-02</TD><TD>-3.73</TD><TD>DAP12 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-2424491</TD><TD>76</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.441e-02</TD><TD>-3.71</TD><TD>Fc epsilon receptor (FCERI) signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-2454202</TD><TD>77</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.450e-02</TD><TD>-3.71</TD><TD>zf-C2H2</TD><TD>pfam domains</TD><TD>PF00096</TD><TD>63</TD><TD>1</TD><TD>12733</TD><TD>5</TD>
<TD>klf-1</TD></TR>
<TR><TD>2.727e-02</TD><TD>-3.60</TD><TD>Cytokine Signaling in Immune system</TD><TD>REACTOME pathways</TD><TD>R-CEL-1280215</TD><TD>86</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.727e-02</TD><TD>-3.60</TD><TD>Signaling by EGFR</TD><TD>REACTOME pathways</TD><TD>R-CEL-177929</TD><TD>86</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.758e-02</TD><TD>-3.59</TD><TD>Transcriptional Regulation by TP53</TD><TD>REACTOME pathways</TD><TD>R-CEL-3700989</TD><TD>87</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.854e-02</TD><TD>-3.56</TD><TD>NGF signalling via TRKA from the plasma membrane</TD><TD>REACTOME pathways</TD><TD>R-CEL-187037</TD><TD>90</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.870e-02</TD><TD>-3.55</TD><TD>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</TD><TD>MSigDB lists</TD><TD>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</TD><TD>101</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>2.917e-02</TD><TD>-3.53</TD><TD>Signaling by Insulin receptor</TD><TD>REACTOME pathways</TD><TD>R-CEL-74752</TD><TD>92</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>2.977e-02</TD><TD>-3.51</TD><TD>synapse part</TD><TD>cellular component</TD><TD>GO:0044456</TD><TD>174</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.044e-02</TD><TD>-3.49</TD><TD>Signaling by Rho GTPases</TD><TD>REACTOME pathways</TD><TD>R-CEL-194315</TD><TD>96</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.069e-02</TD><TD>-3.48</TD><TD>HORIUCHI_WTAP_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>HORIUCHI_WTAP_TARGETS_DN</TD><TD>108</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.107e-02</TD><TD>-3.47</TD><TD>Platelet activation, signaling and aggregation</TD><TD>REACTOME pathways</TD><TD>R-CEL-76002</TD><TD>98</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.164e-02</TD><TD>-3.45</TD><TD>BTB</TD><TD>prosite domains</TD><TD>PS50097</TD><TD>112</TD><TD>1</TD><TD>7024</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.202e-02</TD><TD>-3.44</TD><TD>Axon guidance</TD><TD>REACTOME pathways</TD><TD>R-CEL-422475</TD><TD>101</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.333e-02</TD><TD>-3.40</TD><TD>neuronal cell body</TD><TD>cellular component</TD><TD>GO:0043025</TD><TD>195</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.410e-02</TD><TD>-3.38</TD><TD>DNA-binding transcription factor activity, RNA polymerase II-specific</TD><TD>molecular function</TD><TD>GO:0000981</TD><TD>161</TD><TD>1</TD><TD>9362</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>3.424e-02</TD><TD>-3.37</TD><TD>Generic Transcription Pathway</TD><TD>REACTOME pathways</TD><TD>R-CEL-212436</TD><TD>108</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.424e-02</TD><TD>-3.37</TD><TD>Signalling by NGF</TD><TD>REACTOME pathways</TD><TD>R-CEL-166520</TD><TD>108</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.456e-02</TD><TD>-3.37</TD><TD>Developmental Biology</TD><TD>REACTOME pathways</TD><TD>R-CEL-1266738</TD><TD>109</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>3.536e-02</TD><TD>-3.34</TD><TD>cell body</TD><TD>cellular component</TD><TD>GO:0044297</TD><TD>207</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.570e-02</TD><TD>-3.33</TD><TD>cell junction</TD><TD>cellular component</TD><TD>GO:0030054</TD><TD>209</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.584e-02</TD><TD>-3.33</TD><TD>ZINC_FINGER_C2H2_2</TD><TD>prosite domains</TD><TD>PS50157</TD><TD>127</TD><TD>1</TD><TD>7024</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>3.739e-02</TD><TD>-3.29</TD><TD>protein ubiquitination</TD><TD>biological process</TD><TD>GO:0016567</TD><TD>173</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.790e-02</TD><TD>-3.27</TD><TD>BTB</TD><TD>pfam domains</TD><TD>PF00651</TD><TD>98</TD><TD>1</TD><TD>12733</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>3.988e-02</TD><TD>-3.22</TD><TD>Znf_C2H2_sf</TD><TD>interpro domains</TD><TD>IPR036236</TD><TD>115</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>klf-1</TD></TR>
<TR><TD>4.035e-02</TD><TD>-3.21</TD><TD>GO_PROTEIN_UBIQUITINATION</TD><TD>MSigDB lists</TD><TD>GO_PROTEIN_UBIQUITINATION</TD><TD>142</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.092e-02</TD><TD>-3.20</TD><TD>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</TD><TD>144</TD><TD>1</TD><TD>3519</TD><TD>1</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.217e-02</TD><TD>-3.17</TD><TD>Signaling by Wnt</TD><TD>REACTOME pathways</TD><TD>R-CEL-195721</TD><TD>133</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>4.231e-02</TD><TD>-3.16</TD><TD>protein modification by small protein conjugation</TD><TD>biological process</TD><TD>GO:0032446</TD><TD>196</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.338e-02</TD><TD>-3.14</TD><TD>ubiquitin-dependent protein catabolic process</TD><TD>biological process</TD><TD>GO:0006511</TD><TD>201</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.347e-02</TD><TD>-3.14</TD><TD>somatodendritic compartment</TD><TD>cellular component</TD><TD>GO:0036477</TD><TD>255</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.509e-02</TD><TD>-3.10</TD><TD>modification-dependent protein catabolic process</TD><TD>biological process</TD><TD>GO:0019941</TD><TD>209</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.532e-02</TD><TD>-3.09</TD><TD>ZINC_FINGER_C2H2_1</TD><TD>prosite domains</TD><TD>PS00028</TD><TD>161</TD><TD>1</TD><TD>7024</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>4.534e-02</TD><TD>-3.09</TD><TD>Signaling by GPCR</TD><TD>REACTOME pathways</TD><TD>R-CEL-372790</TD><TD>143</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>4.572e-02</TD><TD>-3.09</TD><TD>BTB</TD><TD>smart domains</TD><TD>SM00225</TD><TD>126</TD><TD>1</TD><TD>5448</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.658e-02</TD><TD>-3.07</TD><TD>modification-dependent macromolecule catabolic process</TD><TD>biological process</TD><TD>GO:0043632</TD><TD>216</TD><TD>1</TD><TD>9166</TD><TD>2</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.724e-02</TD><TD>-3.05</TD><TD>Hemostasis</TD><TD>REACTOME pathways</TD><TD>R-CEL-109582</TD><TD>149</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>4.736e-02</TD><TD>-3.05</TD><TD>BTB/POZ_dom</TD><TD>interpro domains</TD><TD>IPR000210</TD><TD>137</TD><TD>1</TD><TD>14190</TD><TD>5</TD>
<TD>kel-8</TD></TR>
<TR><TD>4.788e-02</TD><TD>-3.04</TD><TD>Adaptive Immune System</TD><TD>REACTOME pathways</TD><TD>R-CEL-1280218</TD><TD>151</TD><TD>1</TD><TD>3154</TD><TD>1</TD>
<TD>M117.3</TD></TR>
<TR><TD>4.895e-02</TD><TD>-3.02</TD><TD>ZnF_C2H2</TD><TD>smart domains</TD><TD>SM00355</TD><TD>135</TD><TD>1</TD><TD>5448</TD><TD>2</TD>
<TD>klf-1</TD></TR>
<TR><TD>4.970e-02</TD><TD>-3.00</TD><TD>synapse</TD><TD>cellular component</TD><TD>GO:0045202</TD><TD>292</TD><TD>1</TD><TD>11604</TD><TD>2</TD>
<TD>kel-8</TD></TR>
</TABLE>
</BODY></HTML>
